M. Scharl

Discipline

Psychologie (3) Anthropologie biologique (1)

Type de document

Articles (19) Recensions (2) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Patients (17) Patients (17) Inflammatory bowel diseases (16) maladie (15) maladie (15) Swiss (14) cohorte (14) Ulcerative colitis (11) Human beings (11) Manufacturers' agents (10) Commission merchants (10) Crohn's disease (9) adulte (8) Treatment (8) Risk factors (8) adulte (8) risque (7) association (7) Diagnosis (7) Social groups (7) Risk (7) Diagnosis (7) Older people (7) temps (durée) (6) thérapie (6) jeune (6) Time (6) Therapeutics (6) peau (5) gène (5)

Documents écrit par M. Scharl (19) | parle de M. Scharl (0)

Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients.
P. Yoganathan et al. (3 août 2021)
The Influence of Breastfeeding, Cesarean Section, Pet Animals, and Urbanization on the Development of Inflammatory Bowel Disease: Data from the Swiss IBD Cohort Study.
S.A. Lautenschlager et al.
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis.
A. Wyss et al.
The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation.
I.V. Tcymbarevich et al. (7 janv. 2019)
Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
L. Biedermann et al. (2019)
The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.
A. Hiller et al. (2019)
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
N. Roth et al. (2019)
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study.
L. Bon et al. (2019)
Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.
S.R. Vavricka et al. (28 févr. 2018)
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
B. Yilmaz et al. (2018)
Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.
T. Greuter et al. (2018)
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.
T. Greuter et al.
Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study.
S. Schüle et al.
Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.
S. Fagagnini et al. (2017)
Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort.
M.R. Spalinger et al. (2016)
Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.
J. Zeitz et al. (2016)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
D.J. Klionsky et al.
Extraintestinal Manifestations of Inflammatory Bowel Disease.
S.R. Vavricka et al. (2015)
Systematic evaluation of clinical predictors of aggressive ulcerative colitis
S. Vavricka et al. (2015)